Comparison of the effects of ketamine-dexmedetomidine and sevoflurane-sufentanil anesthesia on cardiac biomarkers after cardiac surgery: An observational study

Physiological Research

Volumn 61, Issue 1, 2012, Pages 63-72

  Riha H ^a,b   Kotulak T ^a   Brezina A ^a   Hess, L ^a   Kramar P ^a   Szarszoi O ^a,b   Netuka, I ^a,b   Pirk, J ^a,b  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b Centre for Experimental Cardiovascular Research   (Czech Republic)

Author keywords

Cardiac troponin I; Dexmedetomidine; Ketamine; Myocardial ischemia reperfusion injury; Sevoflurane

Indexed keywords

ANESTHETIC AGENT; BIOLOGICAL MARKER; CARDIOTONIC AGENT; DEXMEDETOMIDINE; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; KETAMINE; SEVOFLURANE; SUFENTANIL;

AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; THORAX SURGERY;

AGED; ANESTHETICS, COMBINED; ANESTHETICS, INHALATION; BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; DEXMEDETOMIDINE; FEMALE; HUMANS; KETAMINE; MALE; METHYL ETHERS; MIDDLE AGED; RETROSPECTIVE STUDIES; SUFENTANIL; THORACIC SURGERY;

EID: 84861568452     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Aantaa R, Jalonen J: Perioperative use of alpha2-adrenoceptor agonists and the cardiac patient. Eur J Anaesthesiol 23: 361-372, 2006.
2. BELHOMME D, PEYNET J, LOUZY M, LAUNAY JM, KITAKAZE M, MENASCHE P: Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 100: II340-II344, 1999.
3. BHANA N, GOA KL, MCCLELLAN KJ: Dexmedetomidine. Drugs 59: 263-268, 2000.
4. BIGNAMI E, BIONDI-ZOCCAI G, LANDONI G, FOCHI O, TESTA V, SHEIBAN I, GIUNTA F, ZANGRILLO A: Volatile anesthetics reduce mortality in cardiac surgery. J Cardiothorac Vasc Anesth 23: 594-599, 2009.
5. BREZINA A, DRABEK T, RIHA H, SCHREIBEROVA J, HESS L: The effect of medetomidine-ketamine anesthesia on hemodynamic parameters during hemorrhagic shock in minipigs. Physiol Res 59: 703-710, 2010.
6. CRAVEN R: Ketamine. Anaesthesia 62 (Suppl 1): 48-53, 2007.
7. CROAL BL, HILLIS GS, GIBSON PH, FAZAL MT, EL-SHAFEI H, GIBSON G, JEFFREY RR, BUCHAN KG, WEST D, CUTHBERTSON BH: Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 114: 1468-1475, 2006.
8. DE HERT SG, TEN BROECKE PW, MERTENS E, VAN SOMMEREN EW, DE BLIER IG, STOCKMAN BA, RODRIGUS IE: Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 97: 42-49, 2002.
9. DE HERT SG, VAN DER LINDEN PJ, CROMHEECKE S, MEEUS R, NELIS A, VAN REETH V, TEN BROECKE PW, DE BLIER IG, STOCKMAN BA, RODRIGUS IE: Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 101: 299-310, 2004.
10. DE HERT SG, PRECKEL B, SCHLACK WS: Update on inhalational anaesthetics. Curr Opin Anaesthesiol 22: 491-495, 2009.
11. DOMANSKI MJ, MAHAFFEY K, HASSELBLAD V, BRENER SJ, SMITH PK, HILLIS G, ENGOREN M, ALEXANDER JH, LEVY JH, CHAITMAN BR, BRODERICK S, MACK MJ, PIEPER KS, FARKOUH ME: Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA 305: 585-591, 2011.
12. EASLEY RB, TOBIAS JD: Pro: dexmedetomidine should be used for infants and children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 22: 147-151, 2008.
13. FLIER S, POST J, CONCEPCION AN, KAPPEN TH, KALKMAN CJ, BUHRE WF: Influence of propofol-opioid vs isoflurane-opioid anaesthesia on postoperative troponin release in patients undergoing coronary artery bypass grafting. Br J Anaesth 105: 122-130, 2010.
14. FRASSDORF J, BOROWSKI A, EBEL D, FEINDT P, HERMES M, MEEMANN T, WEBER R, MULLENHEIM J, WEBER NC, PRECKEL B, SCHLACK W: Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery. J Thorac Cardiovasc Surg 137: 1436-1442, 2009.
15. HANOUZ JL, ZHU L, PERSEHAYE E, MASSETTI M, BABATASI G, KHAYAT A, DUCOURET P, PLAUD B, GERARD JL: Ketamine preconditions isolated human right atrial myocardium: roles of adenosine triphosphate-sensitive potassium channels and adrenoceptors. Anesthesiology 102: 1190-1196, 2005.
16. HUDETZ JA, PATTERSON KM, IQBAL Z, GANDHI SD, BYRNE AJ, HUDETZ AG, WARLTIER DC, PAGEL PS: Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 23: 651-657, 2009.
17. JAAKOLA ML, SALONEN M, LEHTINEN R, SCHEININ H: The analgesic action of dexmedetomidine - a novel alpha 2-adrenoceptor agonist - in healthy volunteers. Pain 46: 281-285, 1991.
18. JALONEN J, HYNYNEN M, KUITUNEN A, HEIKKILA H, PERTTILA J, SALMENPERA M, VALTONEN M, AANTAA R, KALLIO A: Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology 86: 331-345, 1997.
19. KARAKAYA KABUKCU H, SAHIN N, TEMEL Y, AYDOGDU TITIZ T: Hemodynamics in coronary artery bypass surgery: effects of intraoperative dexmedetomidine administration. Anaesthesist 60: 427-431, 2011.
20. KAWANO T, OSHITA S, TAKAHASHI A, TSUTSUMI Y, TANAKA K, TOMIYAMA Y, KITAHATA H, NAKAYA Y: Molecular mechanisms underlying ketamine-mediated inhibition of sarcolemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 102: 93-101, 2005.
21. LANDONI G, BIONDI-ZOCCAI GG, ZANGRILLO A, BIGNAMI E, D'AVOLIO S, MARCHETTI C, CALABRO MG, FOCHI O, GUARRACINO F, TRITAPEPE L, DE HERT S, TORRI G: Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 21: 502-511, 2007.
22. LANDONI G, FOCHI O, TRITAPEPE L, GUARRACINO F, BELLONI I, BIGNAMI E, ZANGRILLO A: Cardiac protection by volatile anesthetics. A review. Minerva Anestesiol 75: 269-273, 2009.
23. LEE TM, CHOU TF: Impairment of myocardial protection in type 2 diabetic patients. J Clin Endocrinol Metab 88: 531-537, 2003.
24. LEVANEN J, MAKELA ML, SCHEININ H: Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium. Anesthesiology 82: 1117-1125, 1995.
25. MASLOV LN, LISHMANOV YB, OELTGEN PR, BARZAKH EI, KRYLATOV AV, NARYZHNAYA NV, PEI JM, BROWN SA: Comparative analysis of the cardioprotective properties of opioid receptor agonists in a rat model of myocardial infarction. Acad Emerg Med 17: 1239-1246, 2010.
26. MULLENHEIM J, FRASSDORF J, PRECKEL B, THAMER V, SCHLACK W: Ketamine, but not S(+)-ketamine, blocks ischemic preconditioning in rabbit hearts in vivo. Anesthesiology 94: 630-636, 2001.
27. MURPHY PG, MYERS DS, DAVIES MJ, WEBSTER NR, JONES JG: The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 68: 613-618, 1992.
28. NEUHAUSER C, PREISS V, FEURER MK, MULLER M, SCHOLZ S, KWAPISZ M, MOGK M, WELTERS ID: Comparison of S-(+)-ketamine- with sufentanil-based anaesthesia for elective coronary artery bypass graft surgery: effect on troponin T levels. Br J Anaesth 100: 765-771, 2008.
29. RAMSAY MA, LUTERMAN DL: Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology 101: 787-790, 2004.
30. WELTERS ID, FEURER MK, PREISS V, MULLER M, SCHOLZ S, KWAPISZ M, MOGK M, NEUHAUSER C: Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates proinflammatory cytokine response during and after cardiopulmonary bypass. Br J Anaesth 106: 172-179, 2011.
31. XIA Z, HUANG Z, ANSLEY DM: Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane. Anesth Analg 103: 527-532, 2006.